The Heel Stick is a test that is performed on newborn babies to check whether they carry fatal genetic disorders or not.
The heel of the baby is pricked within the first 48 hours after the baby is born. After a few drops of blood are taken, five categories of disorders are tested, some of which include Amino Acid Metabolism Disorders, Organic Acid Metabolism Disorders, Fatty Acid Oxidation Disorders, Hemoglobinopathies, and Cystic Fibrosis.
Although the concept was invented back in 1923 by a Danish pediatrician named Paul Drucker, the Heel Stick is a popular procedure that is becoming a hotly-searched topic on the Web.
Heeled Health Screenings
The Heel Stick Checks if Newborns Carry Fatal Disorders
Trend Themes
1. Genetic Disorder Testing - There is an opportunity to develop more advanced and efficient genetic disorder testing methods for newborns.
2. Early Disease Detection - The Heel Stick procedure highlights the need for early disease detection methods in infants to improve treatment outcomes.
3. Online Information and Awareness - There is a growing demand for easily accessible and accurate information about newborn screening procedures.
Industry Implications
1. Medical Diagnostics - The medical diagnostics industry can innovate by developing new technologies and protocols for genetic disorder screening in newborns.
2. Biotechnology - Biotechnology companies can leverage the Heel Stick procedure to develop targeted therapies and interventions for newborns with genetic disorders.
3. Digital Health - Digital health platforms and websites can provide reliable and up-to-date information about newborn screening procedures to enhance public awareness.